Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
William Annett currently holds 3,500 shares of OncoCyte Corp (OCX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, William Annett has been a net neutral trader of OCX stock. They have purchased $0 and sold $0 worth of shares.
William Annett's most recent insider trade was on Jul 26, 2018, when they purchased 3,500 shares at $0.00 per share.
William Annett serves as Executive at OncoCyte Corp (OCX). They have executed 1 insider transactions totaling $0 over their tenure at the company.
William Annett holds the position of Executive at OncoCyte Corp, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 8 years and currently hold a stake valued at $0.
William Annett has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by William Annett was on Jul 26, 2018, when they purchased $0 worth of OCX shares. This transaction involved 3,500 shares at N/A per share.
William Annett currently owns 3,500 shares of OncoCyte Corp (OCX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of William Annett's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. William Annett has 1 Form 4 filings on record as an insider at OncoCyte Corp.
Set alerts for William Annett and 40,000+ other insiders.